Denis V, Cassagnard N, Del Rio M, Cornillot E, Bec N, Larroque C, Jeanson L, Jarlier M, Robert B, Gongora C, Martineau P, Dariavach P Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLoS One. 2022;17(9):e0274390. doi:10.1371/journal.pone.0274390
Colin F, Schauer K, Hamiche A, Martineau P, Borg J-P, Bednar J, Bertolin G, Camoin L, Collette Y, Dimitrov S, Fournier I, Hyenne V, Mendoza-Parra M, Morelli X, Rondé P, Sumara I, Tramier M, Schultz P, Goetz J The NANOTUMOR consortium - Towards the Tumor Cell Atlas. Biol Cell. 2021-02-07. doi:10.1111/boc.202000135
Mairaville C, Martineau P Antibody Identification for Antigen Detection in Formalin-Fixed Paraffin-Embedded Tissue Using Phage Display and Naïve Libraries. Antibodies (Basel). 2021;10(1). doi:10.3390/antib10010004
Chauvin M, Garambois V, Choblet S, Colombo P-E, Chentouf M, Gros L, De Brauwere D-P, Dumas K, Robert B, Jarlier M, Martineau P, Navarro-Teulon I, Pépin D, Chardès T, Pèlegrin A Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival. Int J Oncol. 2021;59(1):43. doi:10.3892/ijo.2021.5223
Chauvin M, Garambois V, Colombo P-E, Chentouf M, Gros L, Brouillet J-P, Robert B, Jarlier M, Dumas K, Martineau P, Navarro-Teulon I, Pépin D, Chardès T, Pèlegrin A Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells. Sci Rep. 2021;11(1):2231. doi:10.1038/s41598-021-81819-y
Mangeat T, Gracia M, Martineau P, Robert B [Strategies of tumor-pecific targeting based on the antigenic tumor specificities and the tumor microenvironment characteristics]. Med Sci (Paris). 2020;36 Hors série n° 1. doi:10.1051/medsci/2020194
Lanotte R, Garambois V, Gaborit N, Larbouret C, Musnier A, Martineau P, Pèlegrin A, Chardès T Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking. Cancer Sci.. 2020;111(7):2508-2525. doi:10.1111/cas.14458
Mas S, Torro A, Bec N, Erschov G, Gongora C, Larroque C, Martineau P, de Juan A, Marco S Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues. Anal. Chim. Acta. 2019;1074. doi:10.1016/j.aca.2019.04.074
Martineau P, Watier H, Turtoi A Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6th antibody industrial symposium, June 25-26, 2018, Montpellier, France. MAbs. May 01, 2019. doi:10.1080/19420862.2019.1612691
Chauvin D, Hust M, Schütte M, Chesnay A, Parent C, Moreira G, Arroyo J, Sanz A, Pugnière M, Martineau P, Chandenier J, Heuzé-Vourc'h N, Desoubeaux G Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model. Front Microbiol. 2019;10. doi:10.3389/fmicb.2019.00600
Mas S, Torro A, Bec N, Gongora C, Larroque C, Martineau P, de Juan A, Marco S MALDI imaging mass spectrometry and chemometric tools to discriminate highly similar colorectal cancer tissues. Talanta. October 10, 2019. doi:10.1016/j.talanta.2019.120455
Kitten O, Martineau P Les formats alternatifs aux anticorps: Fragments et nouvelles charpentes. Med Sci (Paris). 2019;35(12):1092-1097. doi:10.1051/medsci/2019217
Andrade A, Tosi D, Michaud H-A, Coquel F, Desigaud D, Jarlier M, Coquelle A, Pasero P, Bonnefoy N, Martineau P, Del Rio M, Beijersbergen R, Vezzio-Vie N Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer. Cancer Res. 2019;79(11):2933-2946. doi:10.1158/0008-5472.CAN-18-2807
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz L, Roger P, Guiu S, Derocq D, Robin G, Michaud H-A, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget J-P, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29. doi:10.1186/s40425-019-0498-z
Ragulan C, Eason K, Fontana E, Nyamundanda G, Tarazona N, Patil Y, Poudel P, Lawlor R, Del Rio M, Koo S-L, Tan W-S, Sclafani F, Begum R, Teixeira Mendes L, Martineau P, Scarpa A, Cervantes A, Tan I, Cunningham D, Sadanandam A Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Sci Rep. 2019;9(1):7665. doi:10.1038/s41598-019-43492-0
Ogier C, Colombo P-E, Bousquet C, Canterel-Thouennon L, Sicard P, Garambois V, Thomas G, Gaborit N, Jarlier M, Pirot N, Pugnière M, Vie N, Gongora C, Martineau P, Robert B, Pèlegrin A, Chardès T, Larbouret C Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett.. 2018;432. doi:10.1016/j.canlet.2018.06.023
Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry A, Martineau P, Pannequin J, Roche S, Sirvent A Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Mol Med. 2018;10(4). doi:10.15252/emmm.201707918
Sanchez-Martinez D, Allende-Vega N, Orecchioni S, Talarico G, Cornillon A, Vo D-N, Lu Z-Y, Krzywinska E, Anel A, Galvez E, Pardo J, Robert B, Martineau P, Hicheri Y, Bertolini F, Cartron G, Villalba M Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors. Theranostics. 2018;8(14):3856-3869. doi:10.7150/thno.25149
Caucheteur D, Robin G, Parez V, Martineau P Construction of Synthetic Antibody Libraries. Methods Mol. Biol.. 2018;1827. doi:10.1007/978-1-4939-8648-4_5
Caucheteur D, Robin G, Parez V, Martineau P Construction of a Synthetic Antibody Gene Library for the Selection of Intrabodies and Antibodies. Methods Mol. Biol.. 2018;1701. doi:10.1007/978-1-4939-7447-4_12
Leconet W, Chentouf M, du Manoir S, Chevalier C, Sirvent A, Aït-Arsa I, Busson M, Jarlier M, Radosevic-Robin N, Theillet C, Chalbos D, Pasquet J-M, Pèlegrin A, Larbouret C, Robert B Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. Clin Cancer Res. 2017;23(11):2806-2816. doi:10.1158/1078-0432.CCR-16-1316
Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile J, Roger P, Gongora C, Robert J, Tubiana-Mathieu N, Ychou M, Martineau P Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. 2017;76. doi:10.1016/j.ejca.2017.02.003
Cherradi S, Ayrolles-Torro A, Gueguinou N, Denis V, Combes E, Boissiere F, Busson M, Canterel-Thouennon L, Mollevi C, Bibeau F, Ychou M, Martineau P, Gongora C, Del Rio M Antibody targeting of claudin-1 as a potential colorectal cancer therapy. Journal of experimental & clinical cancer research : CR. 2017;36. doi:10.1186/s13046-017-0558-5
Robin G, Sato Y, Desplancq D, Rochel N, Weiss E, Martineau P Restricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody-antigen complexes. Journal of molecular biology. Aug 28 2014. doi:10.1016/j.jmb.2014.08.013
Mazuc E, Guglielmi L, Bec N, Parez V, Hahn C, Mollevi C, Parrinello H, Desvignes J, Larroque C, Jupp R, Dariavach P, Martineau P In-cell intrabody selection from a diverse human library identifies c12orf4 protein as a new player in rodent mast cell degranulation. 2014;9. doi:10.1371/journal.pone.0104998
Institut de Recherche en Cancérologie de
